Scaling up bioprocesses through a CDMO
Roivant Sciences and Cytiva’s Fast Trak services collaborate to accelerate an orphan drug to clinic.
Scaling a mAb process to 1000 L
Translating monoclonal antibody production from microscale to 1000 L.
Moving from non GMP to GMP
Transferring a process from a laboratory-scale idea to GMP-compliant commercial product.
Lentiviral vector scale-up
Simple batch process scales in linear manner from 5 L to 28 L in single-use bioreactors.
Speeding upstream process development
Process intensification and other approaches to increase efficiency.
CDMO technology transfer success
Don’t risk reducing the quality and efficiency of your process during handoff.
mRNA Manuacturing
Learn more about key considerations and strategies in mRNA manufacturing workflow.
Protein production
Upstream, downstream, and analytics support to take you from idea to pure characterized product.
Cell processing
Technologies to close, automate, and digitize your cell therapy process for consistent and scalable production.
Gene therapy
Flexible, scalable solutions to help you quickly add capacity to develop and manufacture your own plasmids and viral vectors.
Viral vaccine production
Manufacturing approaches for novel vaccines to include vaccines that are bacterial, virus, protein polysaccharide or DNA-based.
Accelerate process development
Balancing innovation, speed, and robustness to support biotherapeutic production.